GRFS Grifols Group: Earnings per share for the last twelve months
The partnership of Grifols, S.A. (GRFS) with blood centers and government health services drives the dynamics of the rolling net income per share, which the GURU.Markets service illustrates in this chart; 0.83 represents the current level of this metric. Business efficiency is based on robotic plasma fractionation without human intervention. Currently, Grifols, S.A. (GRFS) is reducing its debt by selling foreign stakes and pivoting away from acquisitions in favor of organic growth.
Analytical breakdowns and data insights for company Grifols Group (GRFS)
- current quotes and average value forecast:
- company stock capitalization data:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Grifols, S.A.|GRFS - Long-Term Liabilities to Capital|Short-Term Debt to Capital Grifols Biemat|GRFS - Company Total Indebtedness|Debt to Book Capitalization Ratio Grifols Biemat|GRFS - Company Long-Term Loans and Borrowings|Company Short-Term Debts Grifols|Quick Ratio grifols.com
- earnings and valuation multiples indicators:
GRFS - Profit After Tax|Expected Profit Grifols, S.A.|GRFS - Market Cap to Earnings|Future Price to Earnings Grifols Group|GRFS - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Grifols|GRFS - Operating income before deduction of amortization|Net earnings per share for the last 12 months Grifols|GRFS - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months grifols.com|GRFS - Expected net earnings per share growth this year|Expected earnings per share growth for next year Grifols, S.A.
- sales and revenue data:
Comprehensive company analysis:GRFS - Grifols
Plasma supply stability amid geopolitical turbulence and customs restrictions directly determines the operational efficiency of Grifols, S.A. By analyzing the EPS trend over the last 12 months, an investor can see the final net profit allocated per share, which allows for an assessment of the business's real yield and distinguishes temporary logistical disruptions from a systemic decline in the asset's fundamental value.
Competing companies
ARGX - Earnings per share for the last twelve months|BioNTech Inc. (BNTX) - Net earnings per share for the last 12 months|abivax.com (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) immunovant.com|Earnings per share for the last twelve months Kiniksa Pharmaceuticals Ltd (KNSA)|Adaptive Biotechnologies Corporation - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) CLDX (celldex.com)|Aurinia Pharma (AUPH) - Net earnings per one share for the last twelve months|BioCryst - Net earnings per share (EPS TTM)|VERA: Earnings per share for the last twelve months|DNTH: Net earnings per share (EPS TTM)|Pharvaris - Earnings per share for the trailing year|ABCL (AbCellera Bio) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Tourmaline|Net earnings per share (EPS TTM) PGEN|PHAR (pharming.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) NKTR (nektar.com)|Upstream Bio (UPB) - Net earnings per one share for the last twelve months|ZBIO: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Immunome Bio|GOSS: Net earnings per share (EPS TTM)|KALV: Earnings per share for the last four quarters|SEPN (septerna.com) - Net earnings per share (EPS TTM)|Pieris Pharmaceuticals, Inc. - Earnings per one share for the last 12 months|Earnings per share for the last twelve months Savara Inc. (SVRA)|Net earnings per share (EPS TTM) Rigel Corp (RIGL)|Earnings per share for the last twelve months AnaptysBio Inc ANAB|astriatx.com (ATXS) - Net earnings per one share for the last twelve months|enGene Bio - Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months RAPT|JBIO: Net earnings per share (EPS TTM)|Aclaris - Earnings per share for the trailing year|KYTX (Kyverna Therapeutics, Inc) - Net earnings per share (EPS TTM)|TLSA: Earnings per share for the trailing year|Net earnings per share for the last 12 months CABA (Cabaletta Bio)|VTYX - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) THTX (Theratechnologies, Inc)|Earnings per share for the last four quarters AVTX (Avalo Therapeutics Inc.)|ELDN: Net earnings per share for the last 12 months|AGEN - Net earnings per share (EPS TTM)|Climb Bio Inc. (CLYM) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ZURA (Zura Bio)|Net earnings per share for the last 12 months ATYR|ADAG: Earnings per share for the trailing year|Net earnings per share (EPS TTM) IMA|Net earnings per share for the last four quarters Shattuck Therapeutics|Net earnings per share (EPS TTM) EQ (Equillium Inc)|Earnings per share for the last four quarters CNTB (Connect Pharma)|IMUX - Earnings per share for the last twelve months|Net earnings per share for the last four quarters atarabio.com ATRA|IFRX: Net earnings per share (EPS TTM)|XFOR (X4 Pharmaceuticals, Inc) - Earnings per share for the last twelve months|Earnings per share for the last twelve months adicetbio.com|CELU: Earnings per share for the trailing year|Earnings per share for the last twelve months INmune Bio Corporation (INMB)|Net earnings per share for the last 12 months Barinthus Biotherapeutics Corp BRNS|Earnings per share for the last twelve months Kezar Life Sciences KZR|Earnings per share for the trailing year SABS|AKTX - Earnings per share for the last twelve months|Earnings per share for the trailing year ENLV (enlivex.com)|Q32 Bio Inc. (QTTB) - Earnings per share for the last twelve months|GeoVax Labs Inc - Earnings per share for the trailing year|EDSA (Edesa Biotech Corp) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months IBIO|Earnings per share for the last twelve months Carisma Therapeutics Inc (CARM)|Net earnings per share (EPS TTM) XTL Biopharmaceuticals Ltd (XTLB)|Net earnings per share (EPS TTM) BOLT (Bolt Biotherapeutics Inc.)|Net earnings per share for the last four quarters HCW Biologics Inc. (HCWB)|Aptevo Therapeutics, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters aimimmuno.com AIM|ADTX (aditxt.com) - Net earnings per share for the last 12 months|GRI (GRI Bio) - Earnings per share for the last twelve months|XRTX (XORTX Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Vyome Therapeutics|Net earnings per share (EPS TTM) REVB|Net earnings per share for the last 12 months indaptusrx.com INDP|Net earnings per share (EPS TTM) SCNI (scinai.com)|Net earnings per share (EPS TTM) CalciMedica, Inc. CALI|AFMD - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Allakos Inc ALLK|HOOK: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months IGM Biosciences Inc. (IGMS)|ITOS (iTeos Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Ocean Biomedical Inc OCEA|Earnings per share for the last twelve months TC BioPharm Ltd (TCBP)|THRD (Third Harmonic Bio, Inc) - Earnings per share for the trailing year
